Epocal Overview
- Year Founded
-
2001

- Status
-
Acquired/Merged
- Latest Deal Type
-
M&A
Epocal General Information
Description
Developer of point-of-care blood diagnostic systems designed to improve outcomes and workflow while transforming care delivery across clinical pathways. The company's system offers blood analysis testing at the patient's side on a single room temperature test card, enabling healthcare providers to streamline patient-testing workflow and accelerate clinical decision-making.
Contact Information
Website
www.epoc.comCorporate Office
- 2060 Walkley Road
- Ottawa, Ontario K1G 3P5
- Canada
Corporate Office
- 2060 Walkley Road
- Ottawa, Ontario K1G 3P5
- Canada
Epocal Valuation & Funding
Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
---|---|---|---|---|---|---|
7. Merger/Acquisition | 12-Jan-2022 | Completed | Generating Revenue | |||
6. Merger/Acquisition | 31-Oct-2017 | Completed | Generating Revenue | |||
5. Merger/Acquisition | 01-Feb-2013 | Completed | Generating Revenue | |||
4. Later Stage VC (Series C) | 10-Apr-2007 | Completed | Generating Revenue | |||
3. Debt - General | 25-Jan-2006 | Completed | Generating Revenue | |||
2. Early Stage VC (Series B) | 07-Apr-2005 | $5M | $8.2M | Completed | Generating Revenue | |
1. Seed Round | 19-Nov-2001 | $3.2M | $3.2M | Completed | Startup |
Epocal Comparisons
Industry
Financing
Details
Epocal Competitors (4)
One of Epocal’s 4 competitors is Hain Lifescience, a Corporate Backed or Acquired company based in Nehren, Germany.
Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
---|---|---|---|---|---|---|
Hain Lifescience | Corporate Backed or Acquired | Nehren, Germany | ||||
SQI Diagnostics | Corporation | Toronto, Canada | ||||
QuantuMDx | Venture Capital-Backed | Newcastle Upon Tyne, United Kingdom | ||||
Kypha | Venture Capital-Backed | Saint Louis, MO |
Epocal Patents
Epocal Recent Patent Activity
Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
---|---|---|---|---|---|
CA-130757-S | Blood analysis system | Inactive | 26-May-2009 | ||
JP-2008501102-A | Mixed electrode | Active | 01-Jun-2004 | ||
JP-5060944-B2 | Mixed electrode | Active | 01-Jun-2004 | ||
JP-5097182-B2 | Diagnostic device incorporating fluid engineering and manufacturing method | Active | 01-Jun-2004 | ||
JP-2010032527-A | Diagnostic device incorporating fluidics and method of manufacture | Active | 01-Jun-2004 | G01N27/26 |
Epocal Former Investors (5)
Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
---|---|---|---|---|
Alere | Corporation | Majority | ||
Covington Capital Corporation | Venture Capital | Minority | ||
Genesys Capital | Venture Capital | Minority | ||
Highland Capital Management | Hedge Fund | Minority | ||
Siemens Healthineers | Corporation | Majority |
Epocal FAQs
-
When was Epocal founded?
Epocal was founded in 2001.
-
Where is Epocal headquartered?
Epocal is headquartered in Ottawa, Canada.
-
What industry is Epocal in?
Epocal’s primary industry is Monitoring Equipment.
-
Is Epocal a private or public company?
Epocal is a Private company.
-
What is Epocal’s current revenue?
The current revenue for Epocal is
. -
How much funding has Epocal raised over time?
Epocal has raised $41.7M.
-
Who are Epocal’s investors?
Alere, Covington Capital Corporation, Genesys Capital, Highland Capital Management, and Siemens Healthineers have invested in Epocal.
-
Who are Epocal’s competitors?
Hain Lifescience, SQI Diagnostics, QuantuMDx, and Kypha are competitors of Epocal.
-
When was Epocal acquired?
Epocal was acquired on 12-Jan-2022.
-
Who acquired Epocal?
Epocal was acquired by Idexx Laboratories.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read blog » -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process »